Article Correctness Is Author's Responsibility: Common Alzheimer’s Treatment Linked to Slower Cognitive Decline

The article below may contain offensive and/or incorrect content.

This shows a model of a head and a brainCholinesterase inhibitors such as galantamine, donepezil, and rivastigmine, appear to generate persistent cognitive benefits, and increased longevity for up to five years in Alzheimer's patients.